Delivery Order SPE2DB20D3103-SPE2DB25FQ2J1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Adderall 20 mg tablets (100-count units) with a ceiling value of $1,932.81. This firm fixed-price, non-set-aside delivery order is scheduled for completion by July 29, 2025, with performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Adderall 10 mg tablets in quantities of 100 units. This firm fixed-price delivery order has a ceiling value of $35,426.45 and is scheduled for completion by August 5, 2025. The contract represents a non-set-aside, competitively awarded action and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Adderall 10 mg tablets in quantities of 100, with a ceiling value of $7,054.28. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the federal medical supply chain. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Adderall tablets (10mg) under a firm fixed-price contract with a ceiling value of $9,584.53. This non-set-aside award represents a competitively awarded delivery order with an ultimate completion date of July 22, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Adderall 10 mg tablets in quantities of 100, with a ceiling value of $3,012.75 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Adderall 15 mg tablets (100 count) with a ceiling value of $5,233.57. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a single pharmaceutical supply transaction under AmerisourceBergen's existing contract vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Adderall 20 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $2,824.08, with an ultimate completion date of August 21, 2025. The contract was competitively awarded with no set-aside designation and is to be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Adderall 5 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,266.02 and an ultimate completion date of September 4, 2025. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,899.03 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Adderall 5 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Adderall 20 mg tablets (100-count units) with a ceiling value of $9,535.69 and an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen Drug Corp's existing...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2J1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Adderall 20 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,744.40 and is structured as a firm fixed-price delivery order, with an ultimate completion date of September 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military healthcare systems and other federal agencies. The company's extensive experience fulfilling competitive federal pharmaceutical contracts demonstrates its capability to meet stringent government procurement requirements for controlled and non-controlled medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 9/10/25 |